Global Nuclear Medicine & Radio Pharmaceuticals Market Research Report 2020

Global Nuclear Medicine & Radio Pharmaceuticals Market Research Report 2020

Table of Contents
1 Nuclear Medicine & Radio Pharmaceuticals Market Overview
1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals
1.2 Nuclear Medicine & Radio Pharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Diagnostic Medicine
1.2.3 Therapeutic Medicine
1.3 Nuclear Medicine & Radio Pharmaceuticals Segment by Application
1.3.1 Nuclear Medicine & Radio Pharmaceuticals Sales Comparison by Application: 2020 VS 2026
1.3.2 Diagnostic Applications
1.3.3 Therapeutic Applications
1.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue 2015-2026
1.4.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales 2015-2026
1.4.3 Nuclear Medicine & Radio Pharmaceuticals Market Size by Region: 2020 Versus 2026
2 Global Nuclear Medicine & Radio Pharmaceuticals Market Competition by Manufacturers
2.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
2.3 Global Nuclear Medicine & Radio Pharmaceuticals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Nuclear Medicine & Radio Pharmaceuticals Market Competitive Situation and Trends
2.5.1 Nuclear Medicine & Radio Pharmaceuticals Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nuclear Medicine & Radio Pharmaceuticals Players (Opinion Leaders)
3 Nuclear Medicine & Radio Pharmaceuticals Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine & Radio Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nuclear Medicine & Radio Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Country
3.3.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.3.2 North America Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Region
3.5.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.6.2 Latin America Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.7.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nuclear Medicine & Radio Pharmaceuticals Historic Market Analysis by Type
4.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2015-2020)
4.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Type (2015-2020)
4.3 Global Nuclear Medicine & Radio Pharmaceuticals Price Market Share by Type (2015-2020)
4.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Nuclear Medicine & Radio Pharmaceuticals Historic Market Analysis by Application
5.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2015-2020)
5.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Application (2015-2020)
5.3 Global Nuclear Medicine & Radio Pharmaceuticals Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nuclear Medicine & Radio Pharmaceuticals Business
6.1 GE Healthcare
6.1.1 Corporation Information
6.1.2 GE Healthcare Description, Business Overview and Total Revenue
6.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GE Healthcare Products Offered
6.1.5 GE Healthcare Recent Development
6.2 Philips Healthcare
6.2.1 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.2.2 Philips Healthcare Description, Business Overview and Total Revenue
6.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Philips Healthcare Products Offered
6.2.5 Philips Healthcare Recent Development
6.3 Siemens Healthcare
6.3.1 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.3.2 Siemens Healthcare Description, Business Overview and Total Revenue
6.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Siemens Healthcare Products Offered
6.3.5 Siemens Healthcare Recent Development
6.4 Toshiba
6.4.1 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.4.2 Toshiba Description, Business Overview and Total Revenue
6.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Toshiba Products Offered
6.4.5 Toshiba Recent Development
6.5 Hitachi
6.5.1 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.5.2 Hitachi Description, Business Overview and Total Revenue
6.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Hitachi Products Offered
6.5.5 Hitachi Recent Development
6.6 Carestream
6.6.1 Carestream Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.6.2 Carestream Description, Business Overview and Total Revenue
6.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Carestream Products Offered
6.6.5 Carestream Recent Development
6.7 Esaote
6.6.1 Esaote Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.6.2 Esaote Description, Business Overview and Total Revenue
6.6.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Esaote Products Offered
6.7.5 Esaote Recent Development
6.8 Shimadzu
6.8.1 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.8.2 Shimadzu Description, Business Overview and Total Revenue
6.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Shimadzu Products Offered
6.8.5 Shimadzu Recent Development
6.9 TriFoil Imaging
6.9.1 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.9.2 TriFoil Imaging Description, Business Overview and Total Revenue
6.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.9.4 TriFoil Imaging Products Offered
6.9.5 TriFoil Imaging Recent Development
6.10 Biosensors International Group, Ltd
6.10.1 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
6.10.2 Biosensors International Group, Ltd Description, Business Overview and Total Revenue
6.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Biosensors International Group, Ltd Products Offered
6.10.5 Biosensors International Group, Ltd Recent Development
7 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
7.4 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nuclear Medicine & Radio Pharmaceuticals Distributors List
8.3 Nuclear Medicine & Radio Pharmaceuticals Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nuclear Medicine & Radio Pharmaceuticals by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nuclear Medicine & Radio Pharmaceuticals by Type (2021-2026)
10.2 Nuclear Medicine & Radio Pharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nuclear Medicine & Radio Pharmaceuticals by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nuclear Medicine & Radio Pharmaceuticals by Application (2021-2026)
10.3 Nuclear Medicine & Radio Pharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nuclear Medicine & Radio Pharmaceuticals by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nuclear Medicine & Radio Pharmaceuticals by Region (2021-2026)
10.4 North America Nuclear Medicine & Radio Pharmaceuticals Estimates and Projections (2021-2026)
10.5 Europe Nuclear Medicine & Radio Pharmaceuticals Estimates and Projections (2021-2026)
10.6 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Estimates and Projections (2021-2026)
10.7 Latin America Nuclear Medicine & Radio Pharmaceuticals Estimates and Projections (2021-2026)
10.8 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Nuclear Medicine & Radio Pharmaceuticals Manufacturers Covered in This Study
Table 5. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 7. Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Nuclear Medicine & Radio Pharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers Nuclear Medicine & Radio Pharmaceuticals Product Types
Table 12. Global Nuclear Medicine & Radio Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Medicine & Radio Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine & Radio Pharmaceuticals as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Nuclear Medicine & Radio Pharmaceuticals Players
Table 16. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Region (2015-2020)
Table 17. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 18. Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) by Region (2015-2020)
Table 19. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 20. North America Nuclear Medicine & Radio Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 21. North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 22. North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 24. Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 25. Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 26. Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 32. Latin America Nuclear Medicine & Radio Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 33. Latin America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 34. Latin America Nuclear Medicine & Radio Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 40. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Type (2015-2020)
Table 41. Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2015-2020)
Table 42. Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) by Type (2015-2020)
Table 43. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2015-2020)
Table 44. Global Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) by Type (2015-2020)
Table 45. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Application (2015-2020)
Table 46. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 47. Global Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2015-2020)
Table 48. GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 49. GE Healthcare Description and Business Overview
Table 50. GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GE Healthcare Main Product
Table 52. GE Healthcare Recent Development
Table 53. Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 54. Philips Healthcare Corporation Information
Table 55. Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Philips Healthcare Main Product
Table 57. Philips Healthcare Recent Development
Table 58. Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 59. Siemens Healthcare Corporation Information
Table 60. Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Siemens Healthcare Main Product
Table 62. Siemens Healthcare Recent Development
Table 63. Toshiba Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 64. Toshiba Corporation Information
Table 65. Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Toshiba Main Product
Table 67. Toshiba Recent Development
Table 68. Hitachi Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 69. Hitachi Corporation Information
Table 70. Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Hitachi Main Product
Table 72. Hitachi Recent Development
Table 73. Carestream Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 74. Carestream Corporation Information
Table 75. Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Carestream Main Product
Table 77. Carestream Recent Development
Table 78. Esaote Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 79. Esaote Corporation Information
Table 80. Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Esaote Main Product
Table 82. Esaote Recent Development
Table 83. Shimadzu Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 84. Shimadzu Corporation Information
Table 85. Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Shimadzu Main Product
Table 87. Shimadzu Recent Development
Table 88. TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 89. TriFoil Imaging Corporation Information
Table 90. TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. TriFoil Imaging Main Product
Table 92. TriFoil Imaging Recent Development
Table 93. Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Corporation Information
Table 94. Biosensors International Group, Ltd Corporation Information
Table 95. Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Biosensors International Group, Ltd Main Product
Table 97. Biosensors International Group, Ltd Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Nuclear Medicine & Radio Pharmaceuticals Distributors List
Table 101. Nuclear Medicine & Radio Pharmaceuticals Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Nuclear Medicine & Radio Pharmaceuticals
Figure 2. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type: 2020 VS 2026
Figure 3. Diagnostic Medicine Product Picture
Figure 4. Therapeutic Medicine Product Picture
Figure 5. Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application: 2020 VS 2026
Figure 6. Diagnostic Applications
Figure 7. Therapeutic Applications
Figure 8. Global Nuclear Medicine & Radio Pharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 9. Global Nuclear Medicine & Radio Pharmaceuticals Sales Capacity (K Units) (2015-2026)
Figure 10. Global Nuclear Medicine & Radio Pharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Nuclear Medicine & Radio Pharmaceuticals Sales Share by Manufacturers in 2020
Figure 12. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine & Radio Pharmaceuticals Revenue in 2019
Figure 14. Nuclear Medicine & Radio Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region in 2019
Figure 19. North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country in 2019
Figure 20. North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country in 2019
Figure 21. U.S. Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country in 2019
Figure 26. Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country in 2019
Figure 27. Germany Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region in 2019
Figure 38. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region in 2019
Figure 39. China Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country in 2019
Figure 62. Latin America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country in 2019
Figure 63. Mexico Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Country in 2019
Figure 71. Turkey Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2015-2020)
Figure 78. Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type in 2019
Figure 79. Revenue Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2015-2020)
Figure 80. Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type in 2019
Figure 81. Global Nuclear Medicine & Radio Pharmaceuticals Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2015-2020)
Figure 83. Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Nuclear Medicine & Radio Pharmaceuticals by Application (2015-2020)
Figure 85. Global Revenue Share of Nuclear Medicine & Radio Pharmaceuticals by Application in 2020
Figure 86. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Philips Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Toshiba Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Hitachi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Carestream Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Esaote Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Shimadzu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. TriFoil Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Biosensors International Group, Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure 98. Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure 99. Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. North America Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs